European Pharmaceutical Policies

The following publication is a summary of key policies toward pharmaceuticals in three European countries, Britain, France and West Germany, in 1989. Four key policy areas are covered: pricing and reimbursement, registration, research and development and patents. Some reference is made to pharmaceutical policies in other European countries where this is thought to be particularly relevant or illuminating.

It provides an overview of key policies and may be regarded as a primer for non-experts.

[gview file="http://www.adamsmith.org/wp-content/uploads/2015/09/European-pharmaceutical-.pdf"]